Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission.
about
Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions.CT-P13 in the treatment of rheumatoid arthritis.bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search.What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice.Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?Doctors' preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment.Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?Driving chronicity in rheumatoid arthritis - perpetuating role of myeloid cells.Synovial tissue macrophages: friend or foe?Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitors.Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis.Drug-free remission: the goal of the future in management of patients with rheumatoid arthritis.Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the Imact of esidual Inflammation Detected via Imaging Tchniques, rug Levels and Patient Characteristics on the Outcome of Dose Taperng of Adalimumab in linical Remissi
P2860
Q30249836-14B1D992-1B04-43A2-90F0-72A46ACE137EQ38676104-A28A36C8-97E1-4BF9-95B3-5598230F7CFAQ38751251-11B6A6CA-90D1-457F-B3D0-F0C5577058E8Q38955830-76A4D10A-ECC3-4D82-8740-16C46A955315Q39023180-99909D94-CB22-4BDA-9940-8A63FAE6A93EQ41146155-36F2D99A-28A7-47C2-9ED4-BE409457802AQ42021846-2264D039-16CF-4626-8659-DD12E14A00B9Q47102960-6CB1A512-8109-4AFB-8A9E-2EA67B239987Q47189951-560163D1-14DB-44C5-853B-92A610BC0BA1Q47212014-F4094E5C-13BC-4DB6-8374-98DC5981EC53Q50594712-A93B3299-83A1-4071-A40E-E3246CCF3F6CQ52320824-6D9D1F70-8F08-4018-9B45-45C768DB3615Q54967304-2117AD62-AEE7-40C5-977A-710BBA958BCDQ56570654-B49AA148-9197-4496-8C7A-627B76C1AA93
P2860
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tapering and discontinuation o ...... al and histological remission.
@ast
Tapering and discontinuation o ...... al and histological remission.
@en
type
label
Tapering and discontinuation o ...... al and histological remission.
@ast
Tapering and discontinuation o ...... al and histological remission.
@en
prefLabel
Tapering and discontinuation o ...... al and histological remission.
@ast
Tapering and discontinuation o ...... al and histological remission.
@en
P2860
P50
P1476
Tapering and discontinuation o ...... al and histological remission.
@en
P2093
Anna Laura Fedele
Giusy Peluso
P2860
P2888
P356
10.1186/S13075-016-0927-Z
P577
2016-02-03T00:00:00Z